Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Wipro
WIT
$19.6B
| $187K | ﹤0.01% |
+83,400
| New | +$198K |
|
|
EHAB
3302
DELISTED
Enhabit
EHAB
| $186K | ﹤0.01% |
13,400
-54,300
| -80% | -$780K |
|
3303
Cibus
CBUS
$147M
| $184K | ﹤0.01% |
10,807
-106
| -1% | -$1.75K |
|
3304
Solid Biosciences
SLDB
$794M
| $184K | ﹤0.01% |
38,763
-13,000
| -25% | -$78.1K |
|
3305
Protara Therapeutics
TARA
$220M
| $184K | ﹤0.01% |
58,906
-8,094
| -12% | -$26.7K |
|
|
VAPO
3306
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $184K | ﹤0.01% |
34,949
+5,225
| +18% | +$48.5K |
|
|
XELA
3307
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $184K | ﹤0.01% |
+23,669
| New | +$287K |
|
|
CRON
3308
Cronos Group
CRON
$1.06B
| $183K | ﹤0.01% |
+94,100
| New | +$211K |
|
3309
Fusion Fuel Green
HTOO
$18.7M
| $183K | ﹤0.01% |
2,183
+1,357
| +164% | +$170K |
|
3310
FreightCar America
RAIL
$261M
| $183K | ﹤0.01% |
58,600
-28,000
| -32% | -$96.8K |
|
3311
SIFCO Industries
SIF
$161M
| $183K | ﹤0.01% |
60,734
-1,500
| -2% | -$4.45K |
|
|
WKME
3312
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $183K | ﹤0.01% |
17,200
+3,400
| +25% | +$34.6K |
|
3313
Blend Labs
BLND
$431M
| $182K | ﹤0.01% |
182,760
+42,660
| +30% | +$65.4K |
|
3314
Cue Biopharma
CUE
$113M
| $182K | ﹤0.01% |
1,703
-3,020
| -64% | -$288K |
|
3315
AudioCodes
AUDC
$244M
| $181K | ﹤0.01% |
+12,000
| New | +$204K |
|
3316
Duluth Holdings
DLTH
$155M
| $181K | ﹤0.01% |
+28,296
| New | +$180K |
|
3317
Geospace Technologies
GEOS
$94.6M
| $181K | ﹤0.01% |
25,700
+9,900
| +63% | +$54.9K |
|
3318
Gyre Therapeutics
GYRE
$641M
| $181K | ﹤0.01% |
58,392
-99,873
| -63% | -$380K |
|
|
UCL
3319
uCloudlink Group
UCL
$32.8M
| $181K | ﹤0.01% |
45,405
+200
| +0.4% | +$878 |
|
3320
XBiotech
XBIT
$68M
| $181K | ﹤0.01% |
52,495
-48,973
| -48% | -$182K |
|
|
CBIO
3321
Crescent Biopharma
CBIO
$537M
| $180K | ﹤0.01% |
1,431
-1,139
| -44% | -$256K |
|
3322
RBB Bancorp
RBB
$448M
| $180K | ﹤0.01% |
11,600
-18,400
| -61% | -$352K |
|
3323
Cenntro
CENN
$7.89M
| $179K | ﹤0.01% |
647
+134
| +26% | +$43.2K |
|
3324
First Guaranty Bancshares
FGBI
$159M
| $179K | ﹤0.01% |
11,406
-2,000
| -15% | -$40.8K |
|
|
AUMN
3325
DELISTED
Golden Minerals Company
AUMN
| $179K | ﹤0.01% |
35,300
+16,471
| +87% | +$105K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.